Verizon (VZ) EVP Kyle Malady Receives Phantom Stock Award

What Happened

• Kyle Malady, EVP and Group CEO — VZ Business at Verizon Communications (VZ), received a derivative award of 128.695 phantom shares on 2026-09-24. The filing shows a notional price of $13.51 per share, for a total indicated value of $1,739. This was an award/grant (transaction code A) of phantom stock units, not an open-market purchase or sale.

Key Details

• Transaction date: 2026-09-24; Filing date: 2026-09-28 (filed within the standard 2-business-day Form 4 window).
• Units awarded: 128.695 phantom shares at a notional $13.51 each; total indicated value $1,739.
• Shares owned after transaction: Not disclosed in the filing.
• Notes from the filing:
  • Each phantom share is the economic equivalent of a portion of one common share and is settled in cash; payout occurs under events set by the reporting person per the deferred compensation plan (F1).
  • The award includes phantom stock acquired through dividend reinvestment (F2).

Context

• Phantom stock is a cash‑settled deferred compensation instrument and does not involve issuance or transfer of actual Verizon common shares, so it does not change outstanding share count. The grant is informational and reflects compensation/deferral activity rather than a market buy/sell signal.